A Retrospective Community Based Study Evaluating Disability in Migraine Patients Treated with Erenumab-aoee. American Headache Society 61st Annual Scientific Meeting. Philadelphia, PA July 11-14, 2019
A Two-Year Retrospective Review: Community-Based Outpatient Infusion Center Acute Treatment of Refractory Migraine. American Headache Society 58th Annual Scientific Meeting, San Diego, CA, June 10, 2016.
Chart Review of Lymphocyte Reconstitution Among MS Patients After Discontinuation of Dimethyl Fumarate American Academy of Neurology, 2021 Virtual Annual Meeting, April 17-22, 2021
Comparison of Skin Cell Immunity in Patients Receiving Treatment with Gilenya (fingolimod) and Healthy Controls. 7th Joint ECTRIMS - ACTRIMS Meeting Paris, France, October 25-28, 2017
Is Chronic Migraine More Common in the Multiple Sclerosis Population? American Headache Society 59th Annual Scientific Meeting. Boston, MA June 9, 2017
Sustained efficacy of botulinum toxin type-A (BTXA) on migraine-related disability over 3 treatment cycles in a community-based setting. Cephalalgia, 29 (Suppl 1) (2009) 145.
